BONE MINERAL DENSITY AND MORPHOMETRIC VERTEBRAL DEFORMITIES IN POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS FOR BREAST CANCER

被引：0
|
作者：
Maldonado-Romero, L. V. [1 ]
Ahijon-Lana, M. [1 ]
Velazquez-Arce, C. [1 ]
Sifuentes Giraldo, W. A. [1 ]
Martinez Janez, N. [2 ]
Vazquez Diaz, M. [1 ]
机构：
[1] Univ Hosp Ramon & Cajal, Rheumatol, Madrid, Spain
[2] Univ Hosp Ramon & Cajal, Oncol, Madrid, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.3986
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0901
引用
收藏
页码：1201 / 1201
页数：1
相关论文
共 50 条
  • [21] Bone mineral density and breast cancer risk in postmenopausal women
    Buist, DSM
    LaCroix, AZ
    Barlow, WE
    White, E
    Weiss, NS
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2001, 54 (04) : 417 - 422
  • [22] Bone mineral density and risk of breast cancer in postmenopausal women
    Xinhua Qu
    Xiaoyu Zhang
    An Qin
    Guangwang Liu
    Zanjing Zhai
    Yongqiang Hao
    Huiwu Li
    Zhenan Zhu
    Kerong Dai
    [J]. Breast Cancer Research and Treatment, 2013, 138 : 261 - 271
  • [23] Bone Density Screening in Postmenopausal Women With Early-Stage Breast Cancer Treated With Aromatase Inhibitors
    Stratton, Jamie
    Hu, Xin
    Soulos, Pamela R.
    Davidoff, Amy J.
    Pusztai, Lajos
    Gross, Cary P.
    Mougalian, Sarah S.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (05) : E505 - E515
  • [24] TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS
    Catalano, A.
    Bellone, F.
    Agostino, R. M.
    Morabito, N.
    Gaudio, A.
    Lasco, A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S549 - S549
  • [25] A phase 3 study of the effect of denosumab therapy on bone mineral density in women receiving aromatase inhibitors for non metastatic breast cancer
    Ellis, G.
    Bone, H. G.
    Chlebowski, R.
    Paul, D.
    Spadafora, S.
    Smith, J.
    Fan, M.
    Jun, S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (03) : 585 - 586
  • [26] Treatment with aromatase inhibitors for breast cancer is associated with bone loss in postmenopausal women
    不详
    [J]. Drugs & Therapy Perspectives, 2009, 25 (10) : 23 - 26
  • [27] Screening for Osteoporosis in Postmenopausal Women With Breast Cancer Receiving Aromatase Inhibitors: Less Is More?
    Dhesy-Thind, Sukhbinder K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (13) : 1408 - 1410
  • [28] Postmenopausal breast cancer, aromatase inhibitors, and bone health
    Heneghan, H. M.
    McKenna, M.
    Walshe, J.
    Rothwell, J.
    Evoy, D.
    Geraghty, J.
    McDermott, E.
    Prichard, R. S.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : 416 - 417
  • [29] Denosumab effect on bone mineral density and urinary-NTX in breast cancer patients receiving aromatase inhibitors
    Masahiro Shibata
    Mai Okumura
    Shin Kawano
    Hirotoshi Noda
    Chihiro Toyota
    Yutaka Mizuno
    [J]. Journal of Bone and Mineral Metabolism, 2023, 41 : 567 - 574
  • [30] Denosumab effect on bone mineral density and urinary-NTX in breast cancer patients receiving aromatase inhibitors
    Shibata, Masahiro
    Okumura, Mai
    Kawano, Shin
    Noda, Hirotoshi
    Toyota, Chihiro
    Mizuno, Yutaka
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2023, 41 (04) : 567 - 574
12345